Published in Health Business Week, October 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nastech Pharmaceutical Company Inc..
Report 1: Nastech Pharmaceutical Company Inc. (NASDAQ:NSTK) reported financial results for the three- and six-month periods ended June 30, 2007.
Revenue for the three months ended June 30, 2007 was $4.9 million, compared to $11.4 million for the three months ended June 30, 2006. The 2006 period included revenue of $10.8 million related to our Parathyroid Hormone (PTH1-34) nasal spray collaboration with Procter &...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-10-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.